Long-term Results of Active Surveillance in the Göteborg Randomized, Population-based Prostate Cancer Screening Trial-Reference-Cited by-同舟云学术

Long-term Results of Active Surveillance in the Göteborg Randomized, Population-based Prostate Cancer Screening Trial

Published:2016-11 Issue:5 Volume:70 Page:760-766
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Godtman Rebecka Arnsrud,Holmberg Erik,Khatami Ali,Pihl Carl-Gustaf,Stranne Johan,Hugosson Jonas

Publisher

Elsevier BV

Subject

Urology

Reference28 articles.

1. Trends in management for patients with localized prostate cancer, 1990-2013;Cooperberg;JAMA,2015

2. Population based study of use and determinants of active surveillance and watchful waiting for low and intermediate risk prostate cancer;Loeb;J Urol,2013

3. The National Board of Health and Welfare, Sweden. Nationella riktlinjer för bröst-, prostata-, tjocktarms- och ändtarmscancervård 2014. http://www.socialstyrelsen.se/Lists/Artikelkatalog/Attachments/19383/2014-4-2.pdf

4. Mottet N, Bellmunt J, Briers E, et al. EAU Guidelines on prostate cancer. http://uroweb.org/wp-content/uploads/09-Prostate-Cancer_LR.pdf

5. Prostate cancer, version 2.2014;Mohler;J Natl Compr Canc Netw,2014

Cited by 139 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term outcomes of the first prospective study of active surveillance for prostate cancer in Japan;International Journal of Clinical Oncology;2024-08-01

2. Japanese clinical practice guidelines for prostate cancer 2023;International Journal of Urology;2024-07-30

3. Outcomes of active surveillance for Japanese patients with prostate cancer (PRIAS‐JAPAN);BJU International;2024-06-17

4. Delaying Surgery in Favorable-Risk Prostate Cancer Patients: An NCDB Analysis of Oncologic Outcomes;Clinical Genitourinary Cancer;2024-06

5. Identification of a 9-gene signature to enhance biochemical recurrence prediction in primary prostate cancer: A benchmarking study using ten machine learning methods and twelve patient cohorts;Cancer Letters;2024-04